by Monash University Credit: Unsplash/CC0 Public Domain A best treatment pathway has been identified for people with multiple sclerosis (MS) whose current medication puts them at risk of a serious brain infection. MS patients who take the highly effective drug natalizumab are monitored regularly for their risk of developing a potentially deadly brain infection known as...